
|Articles|February 6, 2006
States sue over Part D Rx costs
Advertisement
At least five states will appeal directly to the U.S. Supreme Court to block the federal government from billing them for millions of dollars for drugs for former Medicaid patients switched to Medicare Part D plans. Although Congress had assured states that the change would lower their drug costs by 10%, the states contend that a flaw in the financial formula is leading the federal government to overcharge them.
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Pneumococcal Diseases Require Constant Vaccine Development | NCPA 2025
2
FDA Approves Oral Semaglutide for Risk of MACE for Patients With Diabetes
3
Pharmacist-Led Education is the Most Effective Supplement Marketing Strategy | NCPA 2025
4
How Personalized Supplement Counseling Can Drive Pharmacy Revenue | NCPA 2025
5